eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Current issue Archive Manuscripts accepted About the journal Supplements Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
Share:
Share:
Case report

Common variable immunodeficiency in a patient with Noonan syndrome

Öner Özdemir
1
,
Ümmügülsüm Dikici
1
,
Ece Tüsüz Önata
1
,
Recep Polat
2

  1. Division of Allergy and Immunology, Department of Pediatrics, Research and Training Hospital of Sakarya University Medical Faculty, Adapazarı, Sakarya, Türkiye
  2. Division of Pediatric Endocrinology, Research and Training Hospital of Sakarya University Medical Faculty, Adapazarı, Sakarya, Türkiye
Alergologia Polska – Polish Journal of Allergology
Online publish date: 2024/11/09
Article file
- common (1).pdf  [0.34 MB]
Get citation
 
PlumX metrics:
 
1. Roberts AE, Allanson JE, Tartaglia M, et al. Noonan syndrome. Lancet 2013; 381: 333-42.
2. Zenker M, Edouard T, Blair JC, Cappa M. Noonan syndrome: improving recognition and diagnosis. Arch Dis Child 2022; 107: 1073-8.
3. Noonan JA. Noonan syndrome. An update and review for the primary pediatrician. Clin Pediatr (Phila) 1994; 33: 548-55.
4. Allanson JE. Noonan syndrome. Am J Med Genet C Semin Med Genet 2007; 145C: 274-9.
5. van der Burgt I. Noonan syndrome. Orphanet J Rare Dis.2007; 2: 4.
6. Bhambhani V, Muenke M. Noonan syndrome. Am Fam Physician 2014; 89: 37-43.
7. Tajan M, Paccoud R, Branka S, et al. The RASopathy family: consequences of germline activation of the RAS/MAPK pathway. Endocr Rev 2018; 39: 676-700.
8. Romano AA, Allanson JE, Dahlgren J, et al. Noonan syndrome: clinical features, diagnosis, and management guidelines. Pediatrics 2010; 126: 746-59.
9. Tartaglia M, Gelb BD, Zenker M. Noonan syndrome and clinically related disorders. Best Pract Res Clin Endocrinol Metab 2011; 25: 161-79.
10. Siano MA, Marchetti V, Pagano S, et al. Risk of autoimmune diseases in patients with RASopathies: systematic study of humoral and cellular immunity. Orphanet J Rare Dis 2021; 16: 410.
11. Hostoffer Jr RW, Macleish S. Noonan’s syndrome associated with hypogammaglobulinemia. J Allergy Clin Immunol 2005; 115: 160.
12. Ng KF, Goenka A, Manyika F, et al. The multifaceted syndromic primary immunodeficiencies in children. J Clin Med 2023; 12: 4964.
13. Romano AA, Blethen SL, Dana K, Noto RA. Growth hormone treatment in Noonan syndrome: the National Cooperative Growth Study experience. J Pediatr 1996; 128: S18-21.
14. Noordam C, van der Burgt I, Sweep CG, et al. Growth hormone (GH) secretion in children with Noonan syndrome: frequently abnormal without consequences for growth or response to GH treatment. Clin Endocrinol (Oxf) 2001; 54: 53-9.
15. Binder G, Neuer K, Ranke MB, Wittekindt NE. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome. J Clin Endocrinol Metab 2005; 90: 5377-81.
16. Jorge AA, Grimberg A, Dattani MT, Baron J. Disorders of childhood growth. In: Sperling Pediatric Endocrinology. Sperling MA (ed.). Elsevier 2021; 299-356.
17. Marcus KA, Sweep CG, van der Burgt I, Noordam C. Impaired Sertoli cell function in males diagnosed with Noonan syndrome. J Pediatr Endocrinol Metab 2008; 21: 1079-84.
18. Vesterhus P, Aarskog D. Noonan’s syndrome and autoimmune thyroiditis. J Pediatr 1973; 83: 237-40.
19. İkincioğulları A, Kendirli T, Doğu F, et al. Peripheral blood lymphocyte subsets in healthy Turkish children. Turk J Pediatr 2004; 46: 125-30.
20. Aksu G, Genel F, Koturoglu G, et al. Serum immunoglobulin (IgG, IgM, IgA) and IgG subclass concentrations in healthy children: a study using nephelometric technique. Turk J Pediatr 2006; 48: 19-24.
21. Besci Ö, Başer D, Öğülür İ, et al. Reference values for T and B lymphocyte subpopulations in Turkish children and adults. Turk J Med Sci 2021; 51: 1814-24.
Copyright: © Polish Society of Allergology This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivatives 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.


Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.